Dr. Joseph A. Crapotta, MD

Dr. Crapotta practices at Specialty Eye Institute in Jackson, Michigan.

Dr. Crapotta's NPI, 1326070020, was assigned on July 6, 2006. Dr. Crapotta graduated from New York Medical College in 1985. Dr. Crapotta holds Michigan license 4301510750.

Dr. Crapotta's primary practice is Specialty Eye Institute, at 850 W N St Suite 100 Suite 100, Jackson, MI 49202-3196. The practice phone is (877) 852-8463.

Dr. Crapotta's primary practice is Specialty Eye Institute in Jackson, Michigan. Dmand AI also links Dr. Crapotta to 1 medical group, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Crapotta practices. Vendor and product names are available with a free account.

Retina specialist is Dr. Crapotta's primary specialty in the NPI Registry, under taxonomy code 207WX0107X. Dr. Crapotta is board certified in ophthalmology by the American Board of Ophthalmology. Dmand AI has Dr. Crapotta's licenses on file in 6 states: Michigan, California, New York, South Carolina, New Jersey and Illinois.

Dmand AI lists age-related macular degeneration, glaucoma, hypertensive retinopathy, inflammation of iris, laser destruction of retinal or choroid lesions, retinal detachment, retinal occlusion and vision problems among the conditions Dr. Crapotta treats.

CMS data shows 12,250 Medicare services from Dr. Crapotta across 18 procedure codes in 2024, for 378 Medicare patients. Medicare paid $875,613 for them. Every service was in an office.

CMS counts 378 Medicare patients who saw Dr. Crapotta in 2024. The largest group is 75 to 84, with 142 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 14% are also on Medicaid. Their average risk score is 1.59, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Crapotta's median patient age at 74, with 58% women.

In 2024, Dr. Crapotta wrote 312 Medicare Part D claims for 109 patients. 60% of them were for generic drugs. CMS names the drug for 221 of them, across 6 drugs with 11 or more claims each, at $5,763 in total drug cost. In 2023, CMS named 183 claims across 6 drugs.

Dr. Crapotta accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 8 papers to Dr. Crapotta. The most frequent topics are Retinitis, Fundus Oculi and Visual Acuity. Dr. Crapotta has published most often in Ophthalmology. Dr. Crapotta's most frequent co-authors are William R. Freeman, MD, Robert M. Feldman, MD and Michael Henry Goldbaum, MD.

CMS Open Payments shows 41 general payments to Dr. Crapotta from 9 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 78% of the total. Regeneron Pharmaceuticals, Inc. paid the most, $402.

Dmand AI lists 2 awards for Dr. Crapotta, most recently CMS Stage 1 2012 in 2012.

Dr. Crapotta graduated from New York Medical College in 1985. Dr. Crapotta is a member of AAO.

Dr. Crapotta is in network with 17 carriers, including Aetna, Priority Health and United Healthcare. Medicare plans come from the most carriers, 10. Check the plan with the practice before a visit.